Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 8, 2020
Grant Date -
Feb 15, 2018
app pub date -
Mar 15, 2016
filing date -
Mar 16, 2015
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection. In particular, the invention provides a cyclosporine liquid formulation for use as an aerosol for inhalation in a method of preventing or treating pulmonarychronic graft rejection in single lung transplanted patients. The formulation is preferably administered once or twice daily. The formulation may be aerosolized with a nebulizer that comprises features for monitoring the time, date and duration of inhalation by the patient, in order to monitor patient adherence. The formulation according to the invention may be combined with standard immunosuppressants and corticosteroids.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully